These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18700540)

  • 21. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systolic blood pressure: an underestimated cardiovascular risk factor.
    Mancia G; Seravalle G; Grassi G
    J Hypertens Suppl; 2002 Jun; 20(5):S21-7. PubMed ID: 12187912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study.
    Gaciong Z; Placha G
    J Hum Hypertens; 2005 Sep; 19(9):737-43. PubMed ID: 15905888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care.
    Fagard RH; Van den Enden M
    J Hum Hypertens; 2003 Oct; 17(10):681-7. PubMed ID: 14504626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actual blood pressure control: are we doing things right?
    Coca A
    J Hypertens Suppl; 1998 Jan; 16(1):S45-51. PubMed ID: 9534097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history of borderline isolated systolic hypertension.
    Sagie A; Larson MG; Levy D
    N Engl J Med; 1993 Dec; 329(26):1912-7. PubMed ID: 8247055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
    Leonetti G; Cuspidi C; Facchini M; Stramba-Badiale M
    J Hypertens Suppl; 2000 Jul; 18(3):S13-20. PubMed ID: 10952083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hypertension, Part I.
    Moser M
    Am Fam Physician; 1996 May; 53(7):2295-302. PubMed ID: 8638506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent knowledge on the role of diastolic blood pressure in hypertensive patients on treatment].
    Leonetti G; Cuspidi C
    Recenti Prog Med; 2008 Apr; 99(4):191-9. PubMed ID: 18595632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension in the aged: when to treat it?].
    Steiner A; Vetter W
    Schweiz Rundsch Med Prax; 1991 Jun; 80(25):692-5. PubMed ID: 1857900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of mild hypertension on the risks of cardiovascular disease: the Hisayama Study].
    Arima H; Kiyohara Y
    Nihon Rinsho; 2008 Aug; 66(8):1453-7. PubMed ID: 18700541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors for cerebrovascular stroke in a cohort of hypertensive patients].
    Rocha E; Gouveia-Oliveira A; Cotter A; Laranjeiro A; Sousa A; Mendes F; Teixeira H; Galvão J; Miguel JM
    Rev Port Cardiol; 1997 Jun; 16(6):543-56, 508. PubMed ID: 9303608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial ischemia during everyday life in patients with arterial hypertension: prevalence, risk factors, triggering mechanism and circadian variability.
    Uen S; Un I; Fimmers R; Vetter H; Mengden T
    Blood Press Monit; 2006 Aug; 11(4):173-82. PubMed ID: 16810027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Borderline hypertension].
    Yamaguchi I; Miyazawa K
    Rinsho Byori; 1993 Jun; 41(6):632-6. PubMed ID: 8361028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High systolic blood pressure increases the risk of obtaining a disability pension because of cardiovascular disease: a cohort study of 903 174 Swedish men.
    Kark M; Rasmussen F
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):597-602. PubMed ID: 19738474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total cardiovascular risk: a new treatment concept.
    Mancia G
    J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.